Articles and Editorials|

Revolutionizing autoinjector assembly with SHL’s Semi-Modular Automatic Robot Track

Shl Medical Smart
SHL’s SMART is designed to support diverse assembly projects with remarkable efficiency

SHL Medical is excited to announce the publication of its latest article in World Pharmaceutical Frontiers, featuring its innovative Semi-Modular Automatic Robot Track, or SMART. The article takes a closer look on SHL’s SMART system and its role in addressing the increasing demand for high-mix/low-volume production while maintaining the flexibility and efficiency that modern drug development requires.

SMART combines the versatility of manual processes with the efficiency and reliability of automated systems, making it possible to produce smaller batches without compromising on quality or speed. Capable of reaching an annual capacity of 7.5-10 million devices while requiring two or three times less labor than manual assembly setups, SMART can be adapted to assemble various devices, such as SHL’s Molly® and Molly 2.25 mL autoinjectors, all on the same equipment.

Some of the key features highlighted in the article include SMART’s modular design, which allows for quick project changeovers, and its six-axis robots that enable precise and flexible motions. The article also discusses the benefits of SMART’s software and data control system – built on SHL’s extensive experience in automation – in ensuring consistent and transferable data across different projects.

 

 

SMART’s success in supporting the assembly of a newly launched combination product for atopic disorders, offers a promising look into the system’s potential to transform the injection device manufacturing landscape.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News